Literature DB >> 12793725

Mutagenic effects of heavy charged particles.

Juergen Kiefer1.   

Abstract

Heavy charged particles constitute the most important radiation risk in space. Since mutations can give rise to cancer the investigation of their induction may be helpful for risk quantification. This paper describes experiments in a number of mammalian cells performed with a large range of linear energy transfer (LET). RBE values are always found to increase with LET up to about 100 keV/microm and are similar to those suggested by ICRP. Molecular analyses demonstrate that heavy charged particles not only lead to sometimes very large deletions but also to smaller changes which might represent point mutations. Recent evidence shows that repair phenomena play an important role in the processing of initial DNA lesions to mutagenic alterations.

Entities:  

Mesh:

Year:  2002        PMID: 12793725     DOI: 10.1269/jrr.43.s21

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  3 in total

1.  An extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancer.

Authors:  Everett J Moding; Hooney D Min; Katherine D Castle; Moiez Ali; Loretta Woodlief; Nerissa Williams; Yan Ma; Yongbaek Kim; Chang-Lung Lee; David G Kirsch
Journal:  JCI Insight       Date:  2016-07-07

2.  Simulated space radiation-induced mutants in the mouse kidney display widespread genomic change.

Authors:  Mitchell S Turker; Dmytro Grygoryev; Michael Lasarev; Anna Ohlrich; Furaha A Rwatambuga; Sorrel Johnson; Cristian Dan; Bradley Eckelmann; Gwen Hryciw; Jian-Hua Mao; Antoine M Snijders; Stacey Gauny; Amy Kronenberg
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

Review 3.  Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

Authors:  Marco Durante; Silvia C Formenti
Journal:  Front Oncol       Date:  2018-05-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.